| Literature DB >> 24108401 |
Serenella Medici1, Massimiliano Peana, Valeria Marina Nurchi, Maria Antonietta Zoroddu.
Abstract
Coordination of proteins and peptides to metal ions is known to affect their properties, often by a change in their structural organization. Side chains of the residues directly involved in metal binding or very close to the coordination centre may arrange themselves around it, in such a way that they can, for instance, disrupt the protein functions or stabilize a metal complex by shielding it from the attack of water or other small molecules. The conformation of these side chains may be crucial to different biological or toxic processes. In our research we have encountered such behaviour in several cases, leading to interesting results for our purposes. Here we give an overview on the structural changes involving peptide side chains induced by Ni(II) coordination. In this paper we deal with a number of peptides, deriving from proteins containing one or more metal coordinating sites, which have been studied through a series of NMR experiments in their structural changes caused by Ni(II) complexation. Several peptides have been included in the study: short sequences from serum albumin (HSA), Des-Angiotensinogen, the 30-amino acid tail of histone H4, some fragments from histone H2A and H2B, the initial fragment of human protamine HP2 and selected fragments from prion and Cap43 proteins. NMR was the election technique for gathering structural information. Experiments performed for this purpose included 1D ¹H and ¹³C, and 2D HSQC, COSY, TOCSY, NOESY and ROESY acquisitions, which allowed the calculation of the Ni(II) complexes structural models.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24108401 PMCID: PMC6269899 DOI: 10.3390/molecules181012396
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Side reactions that can decrease the stability of [ML] complex. Charges have been omitted for simplicity.
Figure 13D structural models for Ni(II) complexes in a square based pyramidal geometry {NIm, 2N−, NH2, O−} with NH2-DAHK- fragment from human serum albumin (a), and in a square planar mode with: (b) NH2-VIHN- from Des-Angiotensinogen {NIm, 2N−, NH2}, (c) -AKRHR- from histone H4 {NIm, 3N−}, (d) NH2-SHHK from histone H2A {NH2, NIm, 2N−}, (e) -GSYHN- from prion protein {NIm, 3N−}, (f) -SRSHT- from Cap43 protein {NIm, 3N−}. Ni(II) is reported in green and the amino acids according to the chemistry of their atoms: in gray (hydrogen and carbon), red (oxygen), and blue (nitrogen). The models a, b, d and e were obtained by molecular modeling and computational chemistry software HyperChem(tm) 8.0.7 [10], models c and f by simulated annealing program DYANA [11]. Molecular graphics and analyses were performed with the UCSF Chimera package [12].
log K* (4N) values of Ni(II) complexes of comparable XYH peptides.
| Peptide | Protein | Ref. | logK * | Coordination sphere | |
|---|---|---|---|---|---|
| Boc-AGGH | [ | −30.02 | {NIm, 3N−} | ||
| Ac-ELAKHA-Am | Histone H2B | [ | −28.87 | {NIm, 3N−} | |
| Ac-IQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK-Am | Histone H2B | [ | −28.83 | {NIm, 3N−} | |
| Ac-AKRHRK-Am | Histone H4 | [ | −28.70 | {NIm, 3N−} | |
| Ac- SGRGKGGKGLGKGGAKRHRKVL -Am | Histone H4 | [ | −28.67 | {NIm, 3N−} | |
| Ac-TESHHK-Am | Histone H2A | [ | −28.58 | {NIm, 3N−} | |
| Ac-TEAHHK-Am | Histone H2A * | [ | −28.41 | {NIm, 3N−} | |
| Ac-TESHAK-Am | Histone H2A * | [ | −28.23 | {NIm, 3N−} | |
| Ac-AK(Ac)RHRK(Ac)V-Am | Histone H4 | [ | −28.20 | {NIm, 3N−} | |
| Ac-TESAHK-Am | Histone H2A * | [ | −28.18 | {NIm, 3N−} | |
| Ac-TRSRSHTSEGTRSR-Am | Cap43 | [ | −28.16 | {NIm, 3N−} | |
| Ac-TYTEHA-Am | Histone H4 | [ | −27.92 | {NIm, 3N−} | |
| Ac-TASHHK-Am | Histone H2A * | [ | −27.26 | {NIm, 3N−} | |
| NH2-GGHistamine | [ | −22.65 | {Nim, 2N−, NH2} | ||
| NH2-GGH | [ | −21.81 | {Nim, 2N−, NH2} | ||
| NH2-SAHK-Am | Histone H2A * | [ | −21.80 | {Nim, 2N−, NH2} | |
| NH2-VIHN | Des-Angiotensinogen | [ | −19.75 | {Nim, 2N−, NH2} | |
| NH2-DAHK-Am | Albumin | [ | −19.48 | {Nim, 2N−, NH2, O-} | |
| NH2-RTHGQSHYRRRHCSR-Am | Protamine HP2 | [ | −19.29 | {Nim, 2N−, NH2} | |
| NH2-RTHGQ-Am | Protamine HP2 | [ | −19.23 | {Nim, 2N−, NH2} | |
| NH2-SHHK-Am | Histone H2A | [ | −19.14 | {Nim, 2N−, NH2} | |
* modified sequence of Histone H2A.
Figure 2Plot of 1H- and 13C-NMR chemical shift variations (Δδ = δholo − δapo, ppm) of selected analogous sequence with Ni(II) bound in a 4N based coordination mode.
| XY-His-Z sequence | Protein | Ref. | X | Y | His | Z | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hα | Hβ2 | Hβ3 | Hα | Hβ2 | Hβ3 | Hα | Hβ2 | Hβ3 | Hδ2 | Hε1 | Hα | Hβ2 | Hβ3 | |||
| DEKHE | YPK9 | −0.23 | 0.70 | 0.56 | −0.59 | 0.57 | −0.17 | −1.33 | −0.12 | −0.16 | −0.06 | 0.01 | 0.01 | 0.02 | 0.00 | |
| LAKHA | Histone H2B | [ | −0.60 | −0.18 | −0.18 | −1.39 | 0.18 | 0.06 | −1.31 | −0.21 | −0.18 | −0.05 | −0.12 | −0.25 | −0.06 | −0.06 |
| RLAHY | Histone H2B | [ | −0.18 | 0.49 | 0.61 | −0.98 | −0.04 | −0.04 | −1.15 | −0.14 | −0.24 | 0.13 | −0.29 | 0.09 | 0.16 | 0.11 |
| MKHM | Prion Protein | [ | −0.41 | 0.41 | 0.34 | −0.56 | 0.13 | 0.04 | −1.12 | −0.21 | 0.03 | 0.00 | −0.20 | 0.10 | 0.23 | 0.13 |
| SRSHT | Cap43 | [ | −0.31 | 0.41 | 0.35 | −0.32 | −0.15 | −0.15 | −1.09 | −0.17 | −0.17 | −0.02 | −0.18 | 0.04 | 0.16 | |
| AKRHR | Histone H4 | [ | −0.26 | 0.28 | 0.39 | −0.67 | 0.36 | 0.55 | −1.03 | −0.17 | −0.23 | −0.04 | −0.13 | 0.05 | 0.16 | 0.03 |
| SAHK | Histone H2A | [ | 0.51 | −0.79 | −0.62 | −0.61 | -0.06 | −0.78 | 0.34 | −0.04 | −0.19 | −0.01 | −0.07 | |||
| SHHK | Histone H2A | [ | 0.44 | −0.69 | −0.45 | −0.72 | -0.82 | −0.64 | 0.42 | −0.04 | −0.25 | −0.03 | −0.07 | |||
| VIHN | Angiotensin | [ | 0.17 | 0.31 | −0.36 | 0.05 | −0.57 | −0.26 | −0.01 | −0.09 | −0.28 | −0.22 | −0.06 | −0.29 | ||
| DAHK | Albumin | [ | −0.24 | −0.06 | −0.06 | −0.56 | −0.05 | −0.05 | −0.47 | −0.15 | −0.11 | −0.05 | −0.24 | |||
| RTHG | Protamine | [ | 0.59 | 0.03 | 0.18 | −0.20 | −0.37 | −0.45 | 0.01 | −0.20 | −0.06 | −0.27 | −0.10 | |||
| GTHS | Prion | [ | −0.65 | −0.34 | −0.38 | −0.44 | −0.01 | −0.08 | −0.09 | −0.22 | −0.28 | −0.36 |
| XY-His-Z sequence | Protein | Ref. | X | Y | His | Z | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cα | Cβ | Cα | Cβ | Cα | Cβ | Cδ2 | Cε1 | Cα | Cβ | |||||||
| DEKHE | YPK9 | * | 10.77 | 6.87 | 6.21 | −1.54 | 3.17 | 1.45 | −3.70 | 1.51 | −0.11 | −0.03 | ||||
| SRSHT | Cap43 | [ | 11.07 | −3.55 | 6.67 | 1.11 | 1.26 | 1.36 | −3.23 | 1.02 | −0.28 | −0.09 | ||||
| RLAHY | Histone H2B | [ | 10.9 | NA | 5.9 | 1.7 | 1.9 | NA | NA | NA | −1.6 | NA | ||||
| LAKHA | Histone H2B | [ | 10.1 | 0.73 | 5.31 | NA | 3.09 | 1.45 | NA | NA | 3.98 | 3.58 | ||||
| DAHK | Albumin | [ | NA | NA | NA | NA | NA | NA | −2.59 | 1.1 | NA | NA | ||||
| GTHS | Prion | [ | 5.5 | −1.2 | 7 | −1.2 | −3 | 0.7 | −2 | 0 | 0 | 0 |
* Unpublished data. For information about –DEKHE- sequence of YPK9 protein see Refs. [58,59].